4-Antibody AG, of Basel, Switzerland, and the Ludwig Institute for Cancer Research in New York signed a multitarget research and development collaboration with Recepta Biopharma SA, of Sao Paulo, Brazil, the leading Brazilian developer of therapeutic antibodies founded by the Ludwig Institute and Brazilian investors...Auxilium Pharmaceuticals Inc., of Malvern, Pa., and Xstelos Holdings Inc., of New York, filed a lawsuit against Upsher-Smith Laboratories Inc., of San Diego, alleging infringement of

After a gap of three months, New York-based Stemline Therapeutics Inc

Pfizer Inc., of New York, said the FDA approved expansion of its pneumococcal conjugate vaccine, Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), in older children and adolescents 6 through 17 for active immunization against invasive disease caused by the 13 Streptococcus pneumoniae serotypes contained in the vaccine

On Monday, shares of New York-based Keryx gained $2.63, or 76.6 percent, to close at $6.06

Underwriter/ Biotech Company (Symbol) Date Priced Offering Price Per Share** 12/31/12 Share Price Offering Gross (M)** After-Market Performance (%) Aegis Capital Corp. Ampio Pharmaceuticals Inc. (AMPE) (co-lead) 7/16/12 $3.24 $3.59 $17.84 +11% CytRx Corp. (CYTR) (lead) 10/19/12 $2.50 $1.87 $23 -25% Galectin Therapeutics Inc. (GALT) (lead) 3/23/12 $4.50 $2.05 $12 -54% InVivo Therapeutics Holdings Corp. (OTC QB:NVIV) (co-lead) 2/21/12 $2.10 $1.74 $20 -17% Neuralstem Inc. (NYSE:CUR) (lead) 8/15

following its 2012 acquisition of the Actavis Group, of Zug, Switzerland, and began trading Thursday on the New York Stock Exchange under the symbol ACT

Pfizer Inc., of New York, reported data from a Phase IV study showed that Toviaz (fesoterodine fumarate) 8 mg once daily reduced urge urinary incontinence episodes in patients with overactive bladder per 24 hours from baseline to week 12, which was statistically significantly more than Toviaz 4 mg

Immunovative Inc., of New York, said it has discovered material information discovered in connection with its lawsuit against Immunovative Therapies Ltd. (ITL), of Shoham, Israel

New York-based Pfizer Inc

The company has raised €10 million (US$13.3 million) in equity financing from Naarden-based Forbion, seed investor BioGeneration Ventures and New-York-based New Science Ventures...Back in 2006, Pfizer Inc., of New York, halted a Phase III trial of torcetrapib because of fatalities and heart attacks linked to the drug

The company has raised €10 million (US$13.3 million) in equity financing from Naarden-based Forbion, seed investor BioGeneration Ventures and New-York-based New Science Ventures...Back in 2006, Pfizer Inc., of New York, halted a Phase III trial of torcetrapib because of fatalities and heart attacks linked to the drug

4/6/12 Connecticut Retirement Plans and Trust Funds Amgen Inc. (Thousand Oaks, Calif.) Supreme Court said it would take up the case, in which Amgen is appealing a decision from the U.S. Court of Appeals for the Ninth circuit that upheld a federal district court's refusal to hear evidence rebutting fraud-on-the-market claims involving erythropoietins before it certified a class in the shareholder lawsuit 6/12/12 Department of Justice and SEC Pfizer Inc. (New York) Pfizer is paying more than $60M

Forest Laboratories Inc., of New York, said its Canadian subsidiary, Forest Laboratories Canada Inc., received a notice of compliance from Health Canada for Bystolic (nebivolol) tablets, a once-daily beta blocker for hypertension...Pfizer Inc., of New York, said the Committee for Medicinal Products for Human Use of the European Medicines Agency offered a positive opinion on the conditional marketing authorization of bosutinib in the European Union (EU) in chronic phase, accelerated phase and blast

Advanced Cell Technology Inc. (ACT) of Marlborough, Mass., said it reached a settlement agreement with CAMOFI and CAMZHN Master LDC resolving a lawsuit filed in the Supreme Court of New York on the conversion price of certain ACT notes and the exercise price of certain warrants

6/1/12 K-V Pharmaceutical Co. (St. Louis) Filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the Southern District of New York The company will attempt to restructure its financial obligations and deal with liabilities

Actinium Pharmaceuticals Inc., of New York, said Johns Hopkins University School of Medicine in Baltimore joined an ongoing Phase I/II trial of Actimab-A in about 50 elderly patients newly diagnosed with acute myeloid leukemia

Synergy Pharmaceuticals Inc., of New York, reported that its stockholders, at their annual meeting, approved the company's acquisition of New York-based Callisto Pharmaceuticals Inc

Danny Weeks, Wyeth (now part of New York-based Pfizer) sought to have the case dismissed, arguing that it was a product liability claim, so the brand company shouldn't be held responsible for injuries resulting from the use of generics

In that challenging financial environment where capital is hard to raise, Greg Simon, CEO of New York-based Poliwogg, an online crowd-financing source, said there is a whole new group of "30-somethings" who will become passionate investors thanks to the passing into law of the JOBS Act